These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 508564)

  • 1. Timing of indomethacin in the control of prostaglandins, osteoclasts and bone destruction produced by VX2 carcinoma in rabbits.
    Galasko CS; Rawlins R; Bennett A
    Br J Cancer; 1979 Sep; 40(3):360-4. PubMed ID: 508564
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hypercalcemia and tumor-prostaglandins: the VX2 carcinoma model in the rabbit.
    Voelkel EF; Tashjian AH; Franklin R; Wasserman E; Levine L
    Metabolism; 1975 Aug; 24(8):973-86. PubMed ID: 1143092
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bone metastases studied in experimental animals.
    Galasko CS
    Clin Orthop Relat Res; 1981; (155):269-85. PubMed ID: 7014059
    [No Abstract]   [Full Text] [Related]  

  • 4. The effect of prostaglandin synthesis inhibitors and diphosphonates on tumour-mediated osteolysis.
    Galasko CS; Samuel AW; Rushton S; Lacey E
    Br J Surg; 1980 Jul; 67(7):493-6. PubMed ID: 7417751
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gut-mediated hypercalcemia in rabbits bearing VX2 carcinoma: new mechanism for tumor-induced hypercalcemia.
    Doppelt SH; Slovik DM; Neer RM; Nolan J; Zusman RM; Potts JT
    Proc Natl Acad Sci U S A; 1982 Jan; 79(2):640-4. PubMed ID: 6210910
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relationship of bone destruction in skeletal metastases to osteoclast activation and prostaglandins.
    Galasko CS; Bennett A
    Nature; 1976 Oct; 263(5577):508-10. PubMed ID: 972698
    [No Abstract]   [Full Text] [Related]  

  • 7. The effect of methotrexate-loaded bone cement on local destruction by the VX2 tumour.
    Wang HM; Crank S; Oliver G; Galasko CS
    J Bone Joint Surg Br; 1996 Jan; 78(1):14-7. PubMed ID: 8898119
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Angiogenesis inhibitor TNP-470 inhibits human breast cancer osteolytic bone metastasis in nude mice through the reduction of bone resorption.
    Sasaki A; Alcalde RE; Nishiyama A; Lim DD; Mese H; Akedo H; Matsumura T
    Cancer Res; 1998 Feb; 58(3):462-7. PubMed ID: 9458090
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasma concentrations of 13,14-dihydro-15-keto-prostaglandin E2 in rabbits bearing the VX2 carcinoma: effects of hydrocortisone and indomethacin.
    Tashjian AH; Voelkel EF; Levine L
    Prostaglandins; 1977 Aug; 14(2):309-17. PubMed ID: 897222
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of murine tumor growth and prostaglandin synthesis by indomethacin.
    Fulton AM; Levy JG
    Int J Cancer; 1980 Nov; 26(5):669-73. PubMed ID: 6453846
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Control of VX2 carcinoma cell growth in culture by calcium, calmodulin, and prostaglandins.
    Yoneda T; Kitamura M; Ogawa T; Aya S; Sakuda M
    Cancer Res; 1985 Jan; 45(1):398-405. PubMed ID: 3917374
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Indomethacin inhibition of middle ear bone resorption.
    Adachi K; Chole RA; Yee J
    Arch Otolaryngol Head Neck Surg; 1991 Mar; 117(3):267-9. PubMed ID: 1998563
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of 1,25-dihydroxycholecalciferol and prostaglandin E2 in the regulation of human osteoclastic bone resorption in vitro.
    Flanagan AM; Stow MD; Kendall N; Brace W
    Int J Exp Pathol; 1995 Feb; 76(1):37-42. PubMed ID: 7734338
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibiting wear particles-induced osteolysis with doxycycline.
    Zhang C; Tang TT; Ren WP; Zhang XL; Dai KR
    Acta Pharmacol Sin; 2007 Oct; 28(10):1603-10. PubMed ID: 17883947
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prostaglandin E2, interleukin 1alpha, and tumor necrosis factor-alpha increase human osteoclast formation and bone resorption in vitro.
    Lader CS; Flanagan AM
    Endocrinology; 1998 Jul; 139(7):3157-64. PubMed ID: 9645689
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prostaglandin-induced bone resorption by rheumatoid synovia.
    Robinson DR; Tashjian AH; Levine L
    Trans Assoc Am Physicians; 1975; 88():146-60. PubMed ID: 1224433
    [No Abstract]   [Full Text] [Related]  

  • 17. Growth inhibition of transplantable murine colon adenocarcinoma 38 by indomethacin.
    Sato M; Narisawa T; Sano M; Takahashi T; Goto A
    J Cancer Res Clin Oncol; 1983; 106(1):21-6. PubMed ID: 6885896
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prostaglandins as mediators of bone resorption in renal and breast tumours.
    Greaves M; Ibbotson KJ; Atkins D; Martin TJ
    Clin Sci (Lond); 1980 Mar; 58(3):201-10. PubMed ID: 7363561
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prostaglandin as a mediator of bone resorption induced by experimental tooth movement in rats.
    Yamasaki K; Miura F; Suda T
    J Dent Res; 1980 Oct; 59(10):1635-42. PubMed ID: 6932420
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Studies on factors causing tooth resorption. 1. Role of prostaglandins as a chemical mediator on resorption of deciduous teeth in rabbits].
    Arita K; Kato K; Tojo T; Nishino M
    Shoni Shikagaku Zasshi; 1989; 27(3):621-8. PubMed ID: 2489875
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.